Sa Xiao | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Dr. Sa Xiao | Pharmaceutical Science | Best Researcher Award

Chief Pharmacist, Clinical pharmacist from The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, China

Sa Xiao is an experienced Clinical Pharmacist currently working at the Department of Pharmacy, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, Guangdong, China. she has dedicated her career to clinical pharmacy with a focus on providing quality patient care and optimizing pharmaceutical practices. Sa Xiao holds a Master’s degree in Pharmacology and a Bachelor’s degree in Pharmaceutical Engineering. Over the past five years and seven months, she has consistently contributed to clinical pharmacy, focusing on improving therapeutic outcomes and pharmaceutical interventions. Sa Xiao’s role places her at the intersection of clinical application and pharmaceutical research, where she works to enhance drug therapy effectiveness and patient safety. Her work contributes directly to hospital-based pharmaceutical care and supports interdisciplinary collaboration in medical settings. Sa Xiao’s background equips her with both theoretical knowledge and practical clinical experience, positioning her as a valuable asset in the healthcare system. While her current profile emphasizes her clinical expertise, expanding her research portfolio could further elevate her impact in the pharmaceutical field. Her dedication, professional growth, and potential for further research contributions make her a promising candidate for recognition in her domain.

Professional Profile

Education

Sa Xiao has built a strong academic foundation that supports her professional excellence in clinical pharmacy. She began her higher education journey at Huzhou Normal University, where she pursued a Bachelor’s degree in Pharmaceutical Engineering from September 2012 to June 2016. This program provided her with essential knowledge of pharmaceutical sciences, drug formulation, and pharmaceutical manufacturing processes. Her education at this stage focused on understanding drug properties, production, and the basic principles that guide pharmaceutical development. After completing her undergraduate studies, Sa Xiao advanced her academic qualifications by enrolling in Guangdong Medical University, where she earned her Master’s degree in Pharmacology from September 2016 to June 2019. This graduate program allowed her to delve deeper into the study of drug actions, mechanisms, and pharmacokinetics. Through her Master’s studies, she developed a comprehensive understanding of clinical pharmacology, which now directly supports her work as a clinical pharmacist. Both her degrees are recognized by the Ministry of Education, China, affirming the academic rigor and credibility of her educational background. Her academic journey demonstrates a seamless transition from pharmaceutical engineering to clinical application, providing her with the necessary expertise to excel in both pharmaceutical sciences and patient-centered clinical practice.

Professional Experience

Sa Xiao has gained substantial professional experience as a Clinical Pharmacist, holding this role since July 2019 at the Department of Pharmacy, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology. With over five years of experience, she has developed a deep understanding of clinical pharmacy operations, patient care protocols, and hospital pharmaceutical services. Her responsibilities likely include reviewing prescriptions, optimizing medication therapies, ensuring the safe and effective use of drugs, and collaborating with medical teams to enhance patient outcomes. Working in a hospital affiliated with a reputable university has provided her with exposure to clinical research, medical education, and interdisciplinary cooperation. Sa Xiao’s experience is not limited to routine pharmacy tasks; her role also requires ongoing learning and adaptation to the latest pharmaceutical guidelines and therapeutic advancements. Her career has been characterized by dedication to improving patient care and supporting evidence-based clinical decisions. While her profile currently focuses on clinical responsibilities, there is potential for her to expand her contributions to include scientific publications, research studies, and leadership in pharmaceutical innovations. Her professional track record reflects commitment, consistency, and the ability to thrive in a demanding healthcare environment.

Research Interest

Sa Xiao’s research interests are rooted in clinical pharmacy and pharmacology, with a focus on optimizing drug therapies, enhancing patient safety, and improving pharmaceutical care within hospital settings. Her academic and professional background suggests a strong interest in therapeutic drug monitoring, drug interactions, and evidence-based medication management. She is likely driven to explore methods for improving the clinical efficacy of pharmacological treatments and minimizing adverse drug reactions. Additionally, she may be interested in research concerning personalized medicine, dosage adjustments for specific patient populations, and clinical outcomes related to pharmaceutical interventions. Her experience as a clinical pharmacist positions her to contribute valuable insights into hospital-based drug management, prescription review processes, and the practical challenges faced in clinical settings. Future research could also include comparative studies on the effectiveness of different pharmacological treatments and the implementation of clinical pharmacy protocols to improve patient care. By aligning her clinical expertise with focused research initiatives, Sa Xiao has the potential to contribute to both national and international discussions in the field of clinical pharmacology and pharmacy practice. Expanding her research interests to cover these areas would significantly strengthen her academic and professional profile.

Research Skills

Sa Xiao possesses a range of research skills that align with her clinical pharmacy background. Her academic training in pharmacology provided her with expertise in drug action mechanisms, pharmacokinetics, and pharmacodynamics, which are essential for conducting clinical pharmaceutical research. She likely has experience in analyzing clinical data, reviewing case studies, and evaluating therapeutic outcomes in real-world settings. Her role as a clinical pharmacist has refined her skills in prescription auditing, patient counseling, and drug therapy evaluation, which contribute to her ability to design practical, patient-focused research projects. Sa Xiao is also expected to be proficient in using clinical databases, medical literature review systems, and pharmacovigilance tools to support her clinical decision-making and potential research activities. Moreover, she may have developed collaborative skills through working with interdisciplinary teams, which are critical for conducting joint clinical studies and implementing hospital-wide pharmaceutical protocols. To further enhance her research portfolio, acquiring advanced skills in statistical analysis, research methodology, and scientific writing would be beneficial. By building on her current skill set and actively participating in research dissemination through conferences and publications, Sa Xiao can establish herself as a leading contributor in the clinical pharmacy research community.

Awards and Honors

At present, no specific awards or honors have been provided for Sa Xiao. However, her sustained commitment to clinical pharmacy over a period of more than five years at a leading university hospital reflects her professional reliability and growing expertise. Although formal recognitions such as research awards, clinical excellence distinctions, or academic honors have not yet been documented, Sa Xiao’s continuous role in a competitive healthcare environment signifies institutional trust in her capabilities. It is possible that she has received internal recognition for her contributions to patient care, medication management, or quality improvement initiatives within her department. Engaging in national or international pharmaceutical competitions, participating in recognized clinical research projects, and contributing to peer-reviewed publications could open avenues for future awards and honors. Earning formal recognition would not only validate her contributions but also help strengthen her professional profile for broader scientific and clinical acknowledgment. Sa Xiao’s consistent career growth and practical impact within the hospital setting suggest that she is well-positioned to achieve significant honors as she continues to expand her involvement in clinical research and professional development activities in the future.

Conclusion

In conclusion, Sa Xiao is a highly capable clinical pharmacist with a strong educational background and valuable experience in the hospital pharmaceutical sector. Her work at The Sixth Affiliated Hospital, School of Medicine, South China University of Technology demonstrates her ability to apply pharmacological knowledge in a clinical environment, directly benefiting patient care and therapeutic practices. While her current profile is predominantly clinical, there is significant potential for her to make substantial research contributions to the field of clinical pharmacy and pharmacology. Sa Xiao’s foundation in pharmaceutical engineering and pharmacology equips her with both theoretical and practical expertise, which can be further advanced through scientific publications, conference presentations, and research collaborations. By actively participating in research dissemination and seeking broader recognition through professional awards, she can enhance her influence within the scientific and medical communities. Sa Xiao’s dedication, clinical precision, and future research potential position her as an emerging contributor to the advancement of pharmaceutical care and clinical pharmacy research. With further academic engagement and research output, she is likely to achieve greater professional recognition and make impactful contributions to the global healthcare landscape.

Publications Top Notes

1. Depression and Suicide/Self-Injury Signals for Weight Loss Medications: A Disproportionality Analysis of Semaglutide, Liraglutide, and Tirzepatide in FAERS Database

  • Journal: Journal of Affective Disorders

  • Publication Date: 2025-06-14

  • Authors: Wang M, Yang Z, Yan M, Liu S, Xiao S

2. Protective Effects of Aqueous Extract of Wampee Fruit Against Anti-Tubercular Drug-Induced Hepatotoxicity in Rats

  • Journal: Journal of Biological Regulators and Homeostatic Agents

  • Publication Date: 2019-01-01

  • Authors: Guan TM, Xiao S, Liu DC, Liao XH, Li WD, Wu KF, Huang R

 

Phuong Linh Ta | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Ms. Phuong Linh Ta | Pharmaceutical Science | Best Researcher Award

University CEU CArdenal Herrera, Spain

Phuong Linh Ta is an emerging researcher in the field of pharmacology, currently pursuing her doctoral studies at Universidad Cardenal Herrera CEU in Spain. She is a highly motivated scientist with a solid academic foundation and practical experience in pharmaceutical research, particularly focusing on ocular drug delivery systems and antibiotic discovery. Throughout her career, she has actively contributed to impactful projects that address pressing global health concerns, such as the development of new antibiotics and the prevention of cognitive decline associated with diseases like Alzheimer’s. She has consistently demonstrated a passion for contributing to both scientific advancement and community well-being through her involvement in various outreach programs including elderly care and sustainable development challenges. Phuong Linh Ta’s scientific journey is marked by a balanced integration of academic excellence, innovative research, and social engagement. Her participation in prestigious conferences across Europe has allowed her to present her work to the international scientific community, thereby expanding her professional network and research visibility. With her commitment to continuous learning, interdisciplinary collaboration, and practical applications in the pharmaceutical field, Phuong Linh Ta is steadily building a robust research portfolio that holds promise for future breakthroughs in pharmacology and clinical applications.

Professional Profile

Education

Phuong Linh Ta’s educational background showcases a steady progression in pharmaceutical sciences and clinical research. She completed her Master’s degree in Direction and Monitorization of Clinical Trials from Universidad Cardenal Herrera CEU in 2022, equipping her with specialized knowledge in clinical trial design and pharmaceutical study management. Prior to that, she earned her Bachelor’s degree in Pharmacy from the same university in 2021, which provided her with a strong foundation in pharmacological principles, drug formulation, and patient care. She also participated in the Forster Summer School at the University of Mainz in 2019, where she gained international exposure and broadened her academic perspective. Her early academic journey includes completing the International Baccalaureate at Birkerød Gymnasium, HF, IB & Boarding School in Denmark, which highlights her global educational experience. This diverse and international academic pathway has given her a broad cultural and scientific outlook, enhancing her adaptability and communication across different educational and professional environments. Her formal education has been consistently aligned with her research interests, particularly in clinical pharmacology, drug delivery systems, and public health, positioning her well for her doctoral research and future contributions to the pharmaceutical sector.

Professional Experience

Phuong Linh Ta has developed substantial professional experience through various academic roles at Universidad Cardenal Herrera CEU. She is currently engaged as a doctoral student in the Faculty of Pharmacy, focusing on pharmacology research, with her work beginning in November 2022. Her previous roles include serving as a Pharmacy Classroom Assistant, where she provided educational support and facilitated learning for undergraduate students. Additionally, she worked as an Internal Student in the Department of Pharmacology, where she honed her laboratory and research skills through hands-on involvement in pharmaceutical studies. Her collaborative roles in the departments of Languages and Communication further enriched her interpersonal, administrative, and organizational capabilities, demonstrating her versatility and commitment to contributing to different facets of the university environment. These experiences have provided her with a well-rounded understanding of both research and academic operations, preparing her for independent and collaborative work in complex scientific projects. Her sustained professional engagement within the same institution illustrates her reliability, long-term dedication, and growth within the academic community. Her evolving responsibilities have enabled her to build a solid foundation in both teaching and research, setting the stage for her continued contributions to the field of pharmacology.

Research Interest

Phuong Linh Ta’s primary research interests lie at the intersection of pharmacology, drug delivery systems, and clinical applications aimed at improving patient outcomes. She is particularly focused on the development of ocular drug delivery platforms, including the formulation and characterization of ocular inserts to enhance the bioavailability and targeted release of therapeutic agents. Her recent research has concentrated on using alpha-lipoic acid in beta-cyclodextrin complexes for improved delivery to the posterior segment of the eye, which holds significant potential for the treatment of ocular diseases and the prevention of long-term complications associated with high myopia. Additionally, she has been involved in projects that address global health challenges such as the discovery of new antibiotics and the promotion of their rational use, aligning her work with the global fight against antimicrobial resistance. Her interest extends to neuroprotective strategies for the early prevention of cognitive deterioration, reflecting her multidisciplinary approach that bridges pharmaceutical technology with public health priorities. Phuong Linh Ta’s research is deeply rooted in translating laboratory findings into practical healthcare solutions, and she is committed to advancing drug delivery science to make therapeutics more efficient, accessible, and patient-centered.

Research Skills

Phuong Linh Ta possesses a diverse range of research skills that are crucial to her contributions in pharmaceutical sciences. She is proficient in developing and characterizing drug delivery systems, particularly ocular inserts, and has significant experience in in vitro release studies and ex vivo diffusion studies. Her technical expertise includes working with complex molecular assemblies like beta-cyclodextrin complexes, optimizing drug stability and bioavailability. She is skilled in conducting clinical trials, managing pharmacological experiments, and applying service-learning methodologies in educational and research settings. Her involvement in competitive R&D projects has also equipped her with skills in project planning, data analysis, and scientific reporting. Furthermore, she has effectively communicated her research findings at multiple international conferences, indicating her capability in scientific presentation and knowledge dissemination. Phuong Linh Ta’s multilingual abilities—fluency in Vietnamese, Spanish, and English—further enhance her collaborative potential in diverse research environments. Her capacity to integrate laboratory research with clinical applications and her aptitude for both independent and team-based work make her a versatile and competent researcher. She continuously seeks to refine her laboratory techniques, analytical skills, and knowledge of pharmacological systems to remain at the forefront of her field.

Awards and Honors

As of the current stage of her career, Phuong Linh Ta’s recognition is primarily reflected in her selection for multiple competitive research projects and her invitations to present at prestigious scientific conferences across Europe. She has actively participated in national and international conferences such as EVER, the Controlled Release Society (CRS) Annual Meeting, and the Spanish-Portuguese Conference on Controlled Drug Delivery. These platforms have provided her with opportunities to showcase her research and gain valuable feedback from global experts. Her consistent involvement in the SWI@CEU project and the DeCo MICOF-CEU project demonstrates the trust her academic institution places in her research capabilities. While she has not yet accumulated formal awards or fellowships, her current academic track record and research engagement highlight her potential for future recognition and academic distinction. Participation in such competitive and high-impact research initiatives serves as an important professional milestone, indicating her emerging status within the scientific community. Moving forward, continued success in publishing peer-reviewed articles and leading independent research projects will likely pave the way for her to receive more significant awards, grants, and honors that will further validate her contributions to pharmaceutical sciences.

Conclusion

Phuong Linh Ta is a dedicated and promising researcher who has steadily built a strong foundation in pharmacology and pharmaceutical research through her education, professional experience, and focused scientific contributions. Her work reflects a commitment to developing innovative drug delivery systems, with particular emphasis on ocular therapeutics and public health impact. While her research is still in the early stages, she has already gained substantial international exposure and actively contributed to community-based and service-learning projects. Her technical skills, multilingual proficiency, and ability to collaborate in multidisciplinary teams make her well-prepared to take on more advanced research challenges in the future. Although there are areas for growth, especially in peer-reviewed publications and leadership of independent projects, her trajectory suggests she is on the right path toward becoming a highly impactful researcher. With further development and continued dedication, Phuong Linh Ta has the potential to significantly contribute to advancements in drug delivery, pharmacology, and patient-centered healthcare solutions. Her work is aligned with global health priorities, and she is well-positioned to make meaningful scientific contributions in both academic and clinical contexts.

Publications Top Notes

  • Title: Optimization and Validation of a High‐Performance Liquid Chromatography (HPLC‐UV) Method for Quantification of α‐Lipoic Acid in Cyclodextrins Complex for Ocular Delivery

  • Authors: Phuong Linh Ta, Lucia Bernat‐Just, Adrián M. Alambiaga‐Caravaca, Vicent Rodilla, Alicia López‐Castellano, Francisco Bosch‐Morell

  • Year: 2025

Mohamed Abdelbaky | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Mohamed Abdelbaky | Pharmaceutical Science | Best Researcher Award

Professor-Biochemistry from Avalon Medical School, Curaçao

Dr. Mohamed Fakhry Mohamed Abdelbaky is a distinguished professor of biochemistry with a robust academic and research background spanning over two decades. He earned his PhD in Biochemistry from Glasgow Caledonian University, UK, in 2011, following his MSc and MB.B.Ch from Minya University, Egypt. Dr. Abdelbaky has held significant academic positions across various international institutions, including Avalon University School of Medicine in Curaçao, Texila American University in Guyana, and Al Maarefa University in Saudi Arabia. His roles have encompassed curriculum development, teaching, student evaluation, and administrative leadership. His research interests are diverse, focusing on molecular biology, cancer research, and pharmacological studies, with numerous publications in reputable journals. Dr. Abdelbaky’s commitment to education and research excellence is evident through his active participation in academic committees, mentorship, and continuous professional development. His contributions have significantly advanced the field of biochemistry, making him a valuable asset to the scientific community.

Professional Profile

Education

Dr. Abdelbaky’s educational journey reflects a strong foundation in medical and biochemical sciences. He obtained his Bachelor of Medicine and Surgery (MB.B.Ch) from the Faculty of Medicine, Minya University, Egypt, in 2000. Pursuing his passion for biochemistry, he completed his Master of Science (MSc) in Biochemistry at the same institution in 2006, where his thesis focused on the effects of plasma homocysteine on VEGF levels in platelets and neutrophils. To further enhance his expertise, he pursued a PhD in Biochemistry and Molecular Biology at Glasgow Caledonian University, UK, completing it in 2011. His doctoral research investigated the biological effects of the proto-oncoprotein EVI1 in normal and transformed fibroblasts. This comprehensive educational background has equipped Dr. Abdelbaky with the knowledge and skills necessary to excel in both academic and research settings, contributing significantly to the field of biochemistry.

Professional Experience

Dr. Abdelbaky’s professional career is marked by a series of progressive academic appointments and responsibilities. He began as a Teaching Assistant at Minya University, Egypt, where he was involved in designing and supervising laboratory experiments for medical students. His dedication led to his promotion to Assistant Lecturer and subsequently to Lecturer, where he continued to contribute to teaching and research activities. He expanded his international experience by serving as a Postgraduate Demonstrator at Glasgow Caledonian University, UK, where he supervised laboratory sessions and research projects for science students. Dr. Abdelbaky furthered his academic career as an Assistant Professor at Al Maarefa University in Saudi Arabia, teaching medical biochemistry and genetics to students of various health science programs. He later joined Texila American University in Guyana as an Associate Professor, where he was responsible for curriculum design and delivery of biochemistry and medical genetics courses. Currently, he holds the position of Professor at Avalon University School of Medicine in Curaçao, where he continues to contribute to curriculum development, teaching, and student mentorship. Throughout his career, Dr. Abdelbaky has demonstrated a commitment to academic excellence and leadership in biochemistry education.

Research Interests

Dr. Abdelbaky’s research interests are centered around molecular biology, cancer research, and pharmacological studies. He has a particular focus on understanding the molecular mechanisms underlying various diseases, including cancer and metabolic disorders. His research explores the roles of specific genes and proteins in disease progression and treatment responses. Dr. Abdelbaky is also interested in the development and evaluation of pharmacological agents for disease prevention and therapy. His work often involves investigating the effects of natural compounds and pharmaceuticals on cellular and molecular pathways. Through his research, Dr. Abdelbaky aims to contribute to the development of effective diagnostic and therapeutic strategies for complex diseases, ultimately improving patient outcomes.

Research Skills

Dr. Abdelbaky possesses a comprehensive set of research skills that enable him to conduct advanced studies in biochemistry and molecular biology. He is proficient in tissue culture techniques, allowing for the cultivation and maintenance of various cell lines for experimental purposes. His expertise includes the isolation of DNA, RNA, and proteins, essential for analyzing gene and protein expression. Dr. Abdelbaky is skilled in polymerase chain reaction (PCR) and reverse transcription PCR (RT-PCR), techniques crucial for amplifying and studying specific DNA and RNA sequences. He is experienced in gene knockdown methods, which are used to study gene function by reducing gene expression. Additionally, he is adept at performing agarose and polyacrylamide gel electrophoresis (PAGE) for the separation and analysis of nucleic acids and proteins. These technical skills are fundamental to his research endeavors, enabling him to investigate complex biological processes and contribute valuable insights to the field of biochemistry.

Awards and Honors

Throughout his career, Dr. Abdelbaky has received recognition for his contributions to biochemistry and medical education. He is a member of several prestigious professional societies, including the Academy of Medical Educators (AoME) in the UK, the Egyptian Medical Syndicate, and the Egyptian Society of Medical Biochemistry. His active participation in these organizations reflects his commitment to professional development and collaboration within the scientific community. Dr. Abdelbaky has also contributed to the peer-review process for scientific journals, demonstrating his expertise and dedication to maintaining high standards in research publication. His involvement in continuous medical education (CME) programs and attendance at international conferences further highlight his pursuit of knowledge and excellence in his field. These accolades and affiliations underscore Dr. Abdelbaky’s standing as a respected figure in biochemistry and medical education.

Conclusion

Dr. Mohamed Fakhry Mohamed Abdelbaky’s extensive academic background, international teaching experience, and robust research portfolio position him as a leading figure in the field of biochemistry. His dedication to education is evident through his curriculum development efforts, mentorship, and active participation in academic committees. His research contributions have advanced the understanding of molecular mechanisms in disease and informed the development of therapeutic strategies. Dr. Abdelbaky’s technical expertise and commitment to professional growth have earned him recognition within the scientific community. His multifaceted career reflects a blend of academic excellence, research innovation, and leadership, making him a valuable asset to any institution and a strong candidate for accolades such as the Best Researcher Award.

Publications Top Notes

  1. Title: Enhanced sensitivity to hydrogen peroxide-induced apoptosis in Evi1 transformed Rat1 fibroblasts due to repression of carbonic anhydrase III
    Authors: Roy P, Reavey E, Rayne M, Roy S, Abed El Baky M, Ishii Y, Bartholomew C
    Year: 2010

  2. Title: BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia
    Authors: Roy S, Jørgensen HG, Roy P, Abed El Baky M, Melo JV, Strathdee G, Holyoake TL, Bartholomew C
    Year: 2012

  3. Title: Potential impact of urocortin I on sperm count, motility and sex hormone profiles in normal adult rats
    Authors: Hany A. El Kattawy, Mahmoud A. Naga, Ahmed Shata, Mohamed A. Elbaky
    Year: 2016

  4. Title: PTEN/PI3K/VEGF signaling pathway involved in the protective effect of xanthine oxidase inhibitor febuxostat against endometrial hyperplasia in rats
    Authors: MZ Mohamed, MF Abed El Baky, OA Hassan, HH Mohammed, AM Abdel-Aziz
    Year: 2020

  5. Title: The relation between ACKR4 and CCR7 genes expression and breast cancer metastasis
    Authors: Mostafa M. Mohammed, Olfat Shaker, Maggie M. Ramzy, Shereen S. Gaber, Heba S. Kamel, Mohamed F. Abed EL Baky
    Year: 2021

  6. Title: Aprepitant exerts anti-fibrotic effect via inhibition of TGF-β/Smad3 pathway in bleomycin-induced pulmonary fibrosis in rats
    Authors: Mervat Z. Mohamed, Mohamed F. Abed El Baky, Merhan E. Ali, Heba M. Hafez
    Year: 2022

  7. Title: Mirabegron alleviates acetic acid-induced colitis in rats: role of adiponectin and GSTM1/GSH detoxification pathway
    Authors: Mervat Z. Mohamed, Mohamed F. Abed El Baky, Sahar A. Mokhemer, Heba M. Hafez
    Year: 2023

  8. Title: Cardioprotective effect of Ginger in a rat model of myocardial damage and its possible intervention in PERK-ATF4-CHOP-PUMA apoptotic pathway
    Authors: M. M. Mohammed, N. A. A. Osman, F. M. Moura, M. F. Abedelbaky
    Year: 2023

  9. Title: Vinpocetine alleviates valproic acid-induced hepatotoxicity and neurotoxicity through activation of cAMP and PI3K/AKT/CREB pathway in rats
    Authors: Heba M. Hafez, Mohamed F. Abed El Baky, Sahar A. Mokhemer, Salma M. Hassan, Mervat Z. Mohamed
    Year: Under submission (anticipated 2024 or 2025)

Niclas Nikolai Stephanson | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Mr. Niclas Nikolai Stephanson | Pharmaceutical Science | Best Researcher Award

Scientist from Karolinska University Hospital, Sweden

Niclas Nikolai Stephanson is a seasoned clinical pharmacologist and forensic chemist based at the Karolinska University Hospital in Stockholm, Sweden. With a career spanning over three decades, he has carved out a notable reputation in the scientific community, particularly in the analysis of drugs of abuse. Holding a PhD in Medicine from the prestigious Karolinska Institutet, he combines academic rigor with practical experience. Niclas is a licensed pharmacist, senior chemist, and prolific researcher whose contributions include over 35 peer-reviewed scientific publications. His research focus lies at the intersection of pharmacology and toxicology, with a specialization in mass spectrometry and method development for detecting drugs in biological materials. He plays a pivotal role in improving clinical and forensic diagnostics through enhanced analytical techniques. Niclas’s work has contributed to better accuracy in detecting and quantifying illicit and therapeutic drugs, ultimately supporting public health and justice systems. His long-standing association with one of Europe’s most reputable hospitals is a testament to his dedication, expertise, and continuous contribution to the advancement of clinical pharmacology. Stephanson stands out not only for his technical skills but also for his impactful research that bridges laboratory science with real-world applications in healthcare and law enforcement.

Professional Profile

Education

Niclas Nikolai Stephanson received his academic training at the renowned Karolinska Institutet in Stockholm, Sweden, where he earned his PhD in Medicine in 2007. His doctoral work was rooted in the Department of Medicine and focused on the interdisciplinary field of clinical pharmacology, an area combining pharmacokinetics, pharmacodynamics, and toxicology. Prior to his doctoral studies, Niclas qualified as a licensed pharmacist, which provided him with a strong foundation in pharmaceutical sciences, drug interactions, and patient-centered pharmacotherapy. His dual academic background in pharmacy and medicine positions him at the nexus of research and clinical practice. This educational pathway has enabled him to integrate principles of chemistry, biology, and medicine in his professional work. Niclas’s academic experience at Karolinska Institutet—a globally respected institution known for its role in awarding the Nobel Prize in Physiology or Medicine—further highlights the high standards and intellectual rigor of his training. The comprehensive and multidisciplinary nature of his education has empowered him to design and conduct advanced analytical research while maintaining a deep understanding of clinical implications. Overall, his educational background has significantly influenced his ability to carry out complex method development and toxicological investigations with precision and clinical relevance.

Professional Experience

Niclas Nikolai Stephanson has been professionally affiliated with Karolinska University Hospital in Stockholm since August 1992, where he currently holds the position of Senior Chemist in the Department of Clinical Pharmacology. Over the span of more than three decades, he has contributed significantly to the hospital’s mission of delivering cutting-edge clinical diagnostics and therapeutic monitoring. As a licensed pharmacist and senior forensic chemist, Niclas has specialized in the analysis of drugs of abuse, playing a key role in the development and implementation of advanced analytical techniques for routine and investigational use. His daily responsibilities involve overseeing laboratory operations, mentoring junior staff, and collaborating with clinicians to interpret toxicological results. His long tenure reflects not only technical proficiency but also institutional trust in his expertise and leadership. Working within a hospital setting, he has consistently ensured that his research aligns with real-world clinical demands, particularly in the identification and quantification of illicit substances and medications in complex biological matrices. Stephanson’s role at Karolinska University Hospital also supports legal and forensic proceedings, as accurate drug analysis is crucial for both medical and judicial outcomes. His professional experience highlights a unique blend of scientific inquiry, clinical application, and public health impact.

Research Interests

Niclas Nikolai Stephanson’s research interests are centered on clinical pharmacology, forensic toxicology, and analytical chemistry, with a particular focus on the detection and analysis of drugs of abuse. He is especially committed to method development in toxicological screening, applying advanced techniques such as mass spectrometry to improve the precision and sensitivity of drug detection. His work often explores various biological matrices—ranging from blood and urine to less conventional materials like hair or oral fluid—to assess the presence and metabolism of illicit and therapeutic substances. Niclas’s interest in mass spectrometry enables the high-resolution identification of complex compounds, which is critical for timely and accurate diagnoses in both clinical and forensic settings. He is also interested in validating new protocols for routine use in healthcare facilities, aiming to bridge the gap between research and clinical practice. Additionally, his work contributes to public safety by improving methodologies used in legal and judicial drug testing. Through collaborations and internal projects at Karolinska University Hospital, his research continues to evolve in response to emerging substances and new analytical challenges. Overall, his interests reflect a strong alignment with societal needs in healthcare and law enforcement, emphasizing both scientific innovation and practical application.

Research Skills

Niclas Nikolai Stephanson possesses a robust set of research skills that underscore his success as a senior clinical chemist and academic contributor. One of his core strengths lies in advanced method development, particularly in the field of forensic toxicology, where he designs, tests, and refines techniques for detecting drugs of abuse in biological matrices. His proficiency in mass spectrometry—including LC-MS/MS and GC-MS systems—is central to his work, enabling precise identification and quantification of substances even in trace amounts. Niclas is also skilled in biological sample preparation, including extraction and purification techniques that are critical for ensuring reliable analytical results. He demonstrates strong data analysis and validation abilities, ensuring that his methods meet rigorous standards for reproducibility, sensitivity, and specificity. In addition, he has experience in regulatory compliance and quality assurance, ensuring that laboratory practices align with healthcare and forensic standards. His skill set extends to scientific writing and publication, as evidenced by his record of more than 35 peer-reviewed articles. These competencies, combined with his practical knowledge of clinical workflows, empower him to translate complex research into diagnostic and therapeutic tools. His research skills are not only technical but also strategic, aiming to meet real-world challenges with innovative scientific solutions.

Awards and Honors

Although specific awards or honors for Niclas Nikolai Stephanson are not explicitly listed, his sustained position at Karolinska University Hospital and the volume of his peer-reviewed publications are indicative of high professional recognition and esteem. Holding a senior chemist position at one of Europe’s leading medical institutions is a reflection of both his expertise and institutional trust in his abilities. His role in the department of Clinical Pharmacology implies consistent recognition through internal appointments, research responsibilities, and possibly departmental accolades for contributions to method development and toxicological analysis. Publishing over 35 scientific articles in peer-reviewed journals also suggests peer recognition and validation of his work within the scientific community. It is not uncommon in the medical sciences for researchers with such a track record to be involved in national and international working groups or to serve as peer reviewers or advisors in forensic and clinical pharmacology. His continued association with the Karolinska Institutet—home to Nobel-level research—implies a professional standing that exceeds routine recognition. While specific honors may not be documented publicly, his contributions and career longevity highlight a professional trajectory marked by consistent achievement and expert-level contribution to clinical science.

Conclusion

Niclas Nikolai Stephanson stands as a highly accomplished clinical pharmacologist and forensic chemist whose contributions span research, diagnostics, and public health. His work at Karolinska University Hospital since 1992, combined with a PhD from Karolinska Institutet, demonstrates a career dedicated to scientific excellence and societal impact. He has specialized in the development of analytical methods using mass spectrometry to detect drugs of abuse, contributing to over 35 peer-reviewed publications. His research not only enhances clinical decision-making but also supports forensic and legal systems by ensuring accurate and timely drug testing. While his achievements are impressive, expanding his international collaborations and diversifying his research themes could further amplify his academic influence. Nonetheless, his sustained excellence and deep specialization in clinical pharmacology make him a valuable asset to the scientific and medical community. Stephanson’s profile exemplifies the rare blend of research depth, clinical utility, and long-term dedication, positioning him as a strong candidate for prestigious honors such as the Best Researcher Award. His work bridges the gap between bench science and bedside application, marking him as a leader in toxicological innovation and a model for aspiring researchers in the field.

Publications Top Notes

  1. Title: Application of liquid chromatography combined with high resolution mass spectrometry for urine drug testing
    Authors: O.M.L. Beck (Olof M.L.), A. Rylski (Alexia), N.N. Stephanson (Nikolai N.)
    Citations: 4

  2. Title: Use of LC–HRMS in full scan-XIC mode for multi-analyte urine drug testing – a step towards a ‘black-box’ solution?
    Authors: N.N. Stephanson (Nikolai N.), P. Signell (Patrick), A. Helander (Anders), O.M.L. Beck (Olof M.L.)
    Year: 2017
    Citations: 19

Eman Zahran | Pharmaceutical Science | Best Academic Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Eman Zahran | Pharmaceutical Science | Best Academic Researcher Award

Associate Professor of Pharmacognosy from Deraya university, Egypt

Dr. Eman Maher Zahran is a distinguished academic and researcher in the field of pharmacognosy, currently serving as an Associate Professor at Deraya University’s Faculty of Pharmacy. With a career rooted in natural product research, her work spans the morphological study of medicinal plants to the biological activities of phytoconstituents. A Ph.D. graduate from Minia University, she has demonstrated unwavering commitment to academic excellence, scientific innovation, and student mentorship. Her research integrates traditional knowledge with advanced technologies such as metabolomic profiling, ESI-HR-MS analysis, and molecular docking. Dr. Zahran has authored over 25 impactful peer-reviewed articles and delivered talks at key international and national pharmaceutical conferences. In addition to her scholarly contributions, she is actively involved in student-centered initiatives, scientific committees, and governmental outreach programs. Her editorial and peer-review work across several international journals further amplifies her impact within the global scientific community. A strong advocate for female leadership in science, she completed the prestigious “The Woman Leads” program at Egypt’s National Training Academy. Dr. Zahran’s blend of academic excellence, innovative research, leadership in community engagement, and dedication to advancing pharmacognosy education positions her as a leading figure in Egypt’s pharmaceutical sciences landscape.

Professional Profile

Education

Dr. Eman Maher Zahran’s educational journey is deeply rooted in Minia University, where she pursued her undergraduate, master’s, and doctoral degrees in Pharmaceutical Sciences with a specialization in Pharmacognosy. She completed her B.Sc. in Pharmaceutical Sciences in 2006 with a cumulative grade of “Very Good.” Her keen interest in medicinal plants and natural product research led her to undertake pre-master courses in 2007, which served as the foundation for her M.Sc. that spanned from 2007 to 2013. Her master’s research involved the detailed phytochemical investigation of plant constituents and their pharmacological evaluation. From 2016 to 2020, she pursued her Ph.D. at the Faculty of Pharmacy, Minia University, where she delved into advanced areas such as metabolomics, molecular docking, and structure elucidation of phytoconstituents. Her doctoral work not only reflected technical expertise but also interdisciplinary collaboration. During this academic trajectory, she also completed specialized training programs and participated in scientific workshops that refined her methodological capabilities. The strength of her education lies in its comprehensive nature, encompassing foundational knowledge, research techniques, and a critical understanding of the pharmacological potential of natural compounds, all of which have laid the groundwork for her ongoing contributions to pharmaceutical research and academia.

Professional Experience

Dr. Zahran’s professional trajectory reflects a steady and strategic ascent through the academic ranks of pharmacognosy. She began her journey as a community pharmacist, transitioning into academia in 2008 as a postgraduate researcher and then as a teaching assistant. Between 2010 and 2012, she served as a grant teaching assistant for Clinical Pharmacy students. From 2016 to 2020, she was appointed Associate Lecturer at the Faculty of Pharmacy, Minia University. In 2020, she was promoted to Assistant Professor, where she continued to lead educational initiatives, mentor students, and develop curricula. As of March 2025, she holds the rank of Associate Professor at Deraya University. Dr. Zahran has also been deeply involved in co-curricular activities, supervising multiple student-led initiatives such as “Hayah,” a student entity focused on scientific and community outreach. She has contributed to post-graduate course development and served on Deraya’s Quality Assurance and Accreditation Unit. Her participation in national-level training programs like “The Woman Leads” demonstrates her leadership and civic engagement. With over 15 years of diverse experience spanning pharmacy practice, teaching, and research, Dr. Zahran has emerged as a dynamic academic professional, recognized for her commitment to excellence, innovation, and interdisciplinary collaboration.

Research Interests

Dr. Zahran’s research interests center on pharmacognosy and natural product chemistry, with a strong emphasis on isolating, identifying, and evaluating bioactive phytoconstituents derived from medicinal plants and marine algae. Her work integrates classical botanical techniques with cutting-edge technologies like ESI-HR-MS analysis and molecular docking. A unique aspect of her research involves the application of network pharmacology to uncover the multi-target mechanisms of natural compounds, especially in treating complex disorders like ADHD and osteoarthritis. Her contributions extend to investigating the wound healing, antifungal, antiplasmodial, and anti-inflammatory properties of various natural substances. Recently, she has delved into combining natural phytochemicals with stem cell therapies to enhance regenerative medicine applications. Additionally, Dr. Zahran’s studies examine the environmental and biochemical effects of phytoconstituents using in vitro, in vivo, and in silico models. This holistic and multidisciplinary approach allows her to bridge the gap between traditional herbal medicine and contemporary pharmacological science. Her interest in neuropsychiatric disorders also reflects a forward-thinking orientation, exploring novel therapeutic avenues. Through her robust pipeline of projects and publications, she continues to identify plant-based compounds with the potential to be developed into pharmaceutical agents, contributing significantly to both academic knowledge and practical healthcare innovation.

Research Skills

Dr. Eman Maher Zahran is equipped with an extensive set of research skills that make her a leading expert in pharmacognosy and natural product research. She is proficient in the morphological and micromorphological analysis of medicinal plants and marine algae, with deep expertise in isolation and structure elucidation techniques for phytochemicals. Her methodological proficiency spans thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC), and advanced mass spectrometric techniques, including ESI-HR-MS. Furthermore, she demonstrates high competence in molecular docking, network pharmacology, and in silico ADME studies, which she integrates seamlessly into phytochemical investigations. Dr. Zahran is also skilled in conducting both in vitro and in vivo biological activity assessments, exploring pharmacodynamics and pharmacokinetics of bioactive compounds. Her research frequently employs interdisciplinary approaches, such as combining plant extracts with mesenchymal stem cells in regenerative medicine models. Additionally, she is adept in scientific writing and publishing, having authored numerous high-impact papers in Scopus-indexed and Web of Science journals. Her peer-review activities and editorial board membership further reflect her critical appraisal capabilities. Collectively, her skills not only underscore her technical competence but also her innovative spirit and dedication to producing translational research that advances healthcare through natural product pharmacology.

Awards and Honors

Dr. Eman Maher Zahran has garnered significant recognition for her academic achievements, both within her institution and the broader scientific community. She was honored by Deraya University for her outstanding academic contributions from 2020 onward, a period during which she published prolifically and advanced numerous research projects. Her active role in student development and community outreach, particularly through her supervision of the “Hayah” entity and ADHD-focused conferences, highlights her multifaceted impact. In 2023, she was selected to join the second cohort of the Egyptian National Training Academy’s “The Woman Leads” program, which is designed to empower and equip promising female leaders in science and education. She serves as an editorial board member and peer reviewer for multiple prestigious journals, including the Journal of Pharmaceutical Chemistry & Chemical Science, Octahedron Drug Research, and journals by the Royal Society of Chemistry. Furthermore, her selection to the scientific committee of international congresses on nanoscience and pharmacology reflects her expertise and respected standing in the academic community. These honors not only affirm her scientific merit but also her leadership, dedication to knowledge dissemination, and her influential role in shaping the future of pharmacognosy in Egypt and beyond.

Conclusion

Dr. Eman Maher Zahran exemplifies the qualities of a dedicated academic, an innovative researcher, and an inspiring mentor. Her career is marked by a relentless pursuit of excellence, from foundational studies in pharmaceutical sciences to cutting-edge research in natural product pharmacology. Her interdisciplinary focus—combining phytochemistry, molecular modeling, and regenerative medicine—demonstrates her commitment to translating traditional medicinal knowledge into therapeutic breakthroughs. Dr. Zahran’s engagement with students, leadership in research committees, and active role in scientific communication reflect her holistic academic persona. Her prolific publication record, participation in international conferences, and collaborations underscore her relevance on both national and global levels. Equally commendable is her devotion to community-based initiatives, particularly in raising awareness and support for neuropsychiatric conditions like ADHD. Her recognition through institutional awards and national leadership programs stands as a testament to her impact. As she continues to expand her research footprint and inspire the next generation of scientists, Dr. Zahran remains a vital force in the advancement of pharmacognosy and pharmaceutical sciences. Her contributions resonate far beyond the laboratory and classroom, positioning her as a role model and a key influencer in the evolving landscape of academic research and community health promotion.

Publications Top Notes

  • Title: Diversity, phytochemical and medicinal potential of the genus Ocimum L. (Lamiaceae)
    Authors: EM Zahran, UR Abdelmohsen, HE Khalil, SY Desoukey, MA Fouad, …
    Year: 2020
    Citations: 86

  • Title: Bioactivity potential of marine natural products from scleractinia-associated microbes and in silico anti-SARS-COV-2 evaluation
    Authors: EM Zahran, A Albohy, A Khalil, AH Ibrahim, HA Ahmed, EM El-Hossary, …
    Year: 2020
    Citations: 41

  • Title: Antioxidant and wound healing potential of Vitis vinifera seeds supported by phytochemical characterization and docking studies
    Authors: T Al-Warhi, EM Zahran, S Selim, MM Al-Sanea, MM Ghoneim, SA Maher, …
    Year: 2022
    Citations: 36

  • Title: Multitarget in silico studies of Ocimum menthiifolium, family Lamiaceae against SARS-CoV-2 supported by molecular dynamics simulation
    Authors: A Albohy, EM Zahran, UR Abdelmohsen, MA Salem, T Al-Warhi, …
    Year: 2022
    Citations: 29

  • Title: Antiulcer potential and molecular docking of flavonoids from Ocimum forskolei Benth., family Lamiaceae
    Authors: EM Zahran, UR Abdelmohsen, AS Hussein, MA Salem, HE Khalil, …
    Year: 2021
    Citations: 27

  • Title: Scabicidal potential of coconut seed extract in rabbits via downregulating inflammatory/immune cross talk: A comprehensive phytochemical/GC-MS and in silico proof
    Authors: EM Zahran, NMR Abdel-Maqsoud, OY Tammam, IM Abdel-Rahman, …
    Year: 2022
    Citations: 23

  • Title: New Acaciin-loaded self-assembled nanofibers as MPro inhibitors against BCV as a surrogate model for SARS-CoV-2
    Authors: SA Mohamad, EM Zahran, MR Abdel Fadeel, A Albohy, MA Safwat
    Year: 2021
    Citations: 23

  • Title: New halogenated compounds from Halimeda macroloba seaweed with potential inhibitory activity against malaria
    Authors: AH Elmaidomy, EM Zahran, R Soltane, A Alasiri, H Saber, CJ Ngwa, …
    Year: 2022
    Citations: 22

  • Title: Metabolic profiling, histopathological anti-ulcer study, molecular docking and molecular dynamics of ursolic acid isolated from Ocimum forskolei Benth. (family Lamiaceae)
    Authors: EM Zahran, UR Abdelmohsen, AT Ayoub, MA Salem, HE Khalil, …
    Year: 2020
    Citations: 21

  • Title: Cytotoxic and anti-diabetic potential, metabolic profiling and in silico studies of Syzygium cumini (L.) Skeels belonging to family Myrtaceae
    Authors: SS Eldin Elhawary, AE Elmotayam, D Alsayed, EM Zahran, MA Fouad, …
    Year: 2022
    Citations: 11

Hafiz Hussain | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Hafiz Hussain | Pharmaceutical Science | Best Researcher Award

Assistant Professor at Cholistan University of Veterinary and Animal Sciences Bahawalpur, Pakistan

Dr. Hafiz Iftikhar Hussain is an esteemed Assistant Professor in the Department of Pathology at Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur, Pakistan. With a strong background in veterinary pathology, he has made significant contributions to research and academia. His expertise lies in bacterial and viral disease pathology in poultry and livestock, with a focus on antibiotic resistance and molecular diagnostics. Dr. Hussain has extensive experience in research methodologies, including whole-genome sequencing, transcriptomic profiling, and biofilm detection. As a dedicated academician, he also serves as Coordinator for undergraduate programs and Additional Director of Student Affairs at CUVAS. He is an active member of several professional associations, including the Pakistan Veterinary Medical Council and the Pakistan Biological Safety Association. His commitment to scientific excellence is evident through his numerous publications, conference presentations, and roles as a reviewer for prestigious journals. Dr. Hussain’s passion for advancing veterinary sciences, particularly in pathology and disease control, underscores his professional journey. His remarkable achievements, including scholarships, best paper awards, and active participation in national and international conferences, reflect his dedication to research, education, and the betterment of animal health sciences in Pakistan and beyond.

Professional Profile

Education

Dr. Hafiz Iftikhar Hussain has an impressive academic background in veterinary sciences and pathology. He earned his Doctor of Philosophy (PhD) in Basic Veterinary Medicine, specializing in Pathobiology, from Huazhong Agricultural University, China, in 2017, with an outstanding score of 81.75%. Prior to his PhD, he completed a Master of Philosophy (M.Phil) in Pathology from the University of Agriculture, Faisalabad, in 2012, focusing on histopathology and toxicology with a commendable CGPA of 3.81/4.00. His foundational education includes a Doctor of Veterinary Medicine (DVM) degree from the University of Agriculture, Faisalabad, completed in 2010, with a CGPA of 3.26/4.00. Dr. Hussain began his academic journey with a Higher Secondary School Certification (F.Sc. Pre-Medical) from the Federal Board of Intermediate and Secondary Education, Islamabad, securing 74% marks in 2005. His early education was completed with a Secondary School Certification in Science from the Board of Intermediate and Secondary Education, Sargodha, where he achieved an excellent 85.77% in 2003. His strong educational foundation has equipped him with advanced knowledge in veterinary pathology, toxicology, and molecular diagnostics, laying the groundwork for his research and academic pursuits in veterinary sciences.

Professional Experience

Dr. Hafiz Iftikhar Hussain has amassed extensive professional experience in veterinary pathology and academia. His career began as a self-employed veterinary doctor at Al-Shifa Veterinary Clinic and Lab in Farooka, Sargodha, from August 2012 to August 2013. He then transitioned to academia as an Assistant Professor in the Department of Veterinary Pathology at PMAS-Arid Agriculture University, Rawalpindi, where he served from July to December 2018. Since December 2018, Dr. Hussain has been an Assistant Professor in the Department of Pathology at Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur. Alongside his teaching responsibilities, he plays a crucial administrative role as the Coordinator for BS Doctor of Veterinary Medicine (DVM) and BS Medical Laboratory Technology programs. Additionally, he serves as the Additional Director of Student Affairs at CUVAS, demonstrating his leadership and commitment to academic excellence. Dr. Hussain is an active member of professional organizations such as the Pakistan Veterinary Medical Council and the Pakistan Biological Safety Association. His experience spans both clinical practice and academia, making him a distinguished figure in veterinary pathology and a mentor for aspiring veterinarians in Pakistan.

Research Interests

Dr. Hafiz Iftikhar Hussain’s research interests lie at the intersection of veterinary pathology, microbiology, and molecular diagnostics. His primary focus is on antibiotic resistance mechanisms, bacterial pathogenesis, and molecular characterization of multidrug-resistant pathogens, particularly Escherichia coli in poultry. He has conducted extensive research on extended-spectrum beta-lactamase (ESBL) detection and whole-genome sequencing to understand resistance genes in bacterial populations. His studies also explore the pathogenesis of viral and bacterial diseases in poultry and livestock, with an emphasis on biofilm formation and detection. Additionally, Dr. Hussain has a keen interest in transcriptomic profiling, protein extraction, and the development of animal models to study disease mechanisms. His research contributes to the global fight against antimicrobial resistance, aiming to develop strategies for better disease control and prevention in veterinary medicine. As an advocate for One Health, he also investigates zoonotic disease transmission and its implications for public health. His work has been widely recognized, earning him numerous publications in high-impact journals and invitations to present at international conferences. Through his research, Dr. Hussain strives to enhance disease diagnosis, treatment, and control strategies to improve animal and human health.

Research Skills

Dr. Hafiz Iftikhar Hussain possesses a comprehensive skill set in veterinary pathology and molecular diagnostics. His expertise includes antibiotic resistance determination, extended-spectrum beta-lactamase (ESBL) detection, and whole-genome re-sequencing. He is proficient in high-performance liquid chromatography (HPLC), polymerase chain reaction (PCR), and DNA, RNA, and protein extraction techniques. His research capabilities extend to RNA sequencing, biofilm formation studies, enzyme-linked immunosorbent assay (ELISA), and spectrophotometry. Dr. Hussain is also experienced in developing cell lines and utilizing animal modeling for disease studies. In addition to his laboratory skills, he is well-versed in various bioinformatics tools, enabling him to analyze complex genomic data efficiently. His proficiency in Microsoft Office, Adobe Photoshop for scientific presentations, and statistical analysis software further supports his research endeavors. Dr. Hussain’s technical expertise has been instrumental in advancing his research on antimicrobial resistance, bacterial pathogenesis, and disease diagnostics. His ability to integrate traditional pathology techniques with modern molecular approaches makes him a valuable contributor to veterinary sciences. With a strong commitment to continuous learning and innovation, he remains at the forefront of veterinary research, working to enhance disease control strategies in animal health.

Awards and Honors

Dr. Hafiz Iftikhar Hussain has received numerous accolades for his academic and research contributions. He was awarded a scholarship from the Chinese Scholarship Council for his PhD studies at Huazhong Agricultural University. Throughout his education, he was a consistent scholarship holder from grade six to his PhD. In recognition of his outstanding research, he won the ‘Best Student Paper Award’ at the First Annual Academic Symposium for International Students in 2018 at Huazhong Agricultural University. His academic achievements include earning the esteemed Sahadat-e-Hifz-ul-Quran certification from Wafaq-ul-Madaris, Islamabad. As a recognized expert, Dr. Hussain is a certified reviewer for the ‘Antimicrobial Resistance & Infection Control’ journal and serves as a reviewer for high-impact journals, including Frontiers in Veterinary Science and PLOS ONE. His dedication to veterinary sciences and research has positioned him as a leader in his field, making significant contributions to veterinary pathology and microbiology. These honors reflect his unwavering commitment to excellence, research innovation, and the advancement of animal health sciences at both national and international levels.

Conclusion

Dr. Hafiz Iftikhar Hussain stands as a distinguished figure in veterinary pathology, academia, and research. His extensive expertise in bacterial and viral disease pathology, antimicrobial resistance, and molecular diagnostics has significantly contributed to veterinary sciences. With a strong academic background, he has successfully combined clinical practice, teaching, and research to mentor future veterinarians. His role as an Assistant Professor, program coordinator, and student affairs director at CUVAS demonstrates his leadership and dedication to education. Through his research, he has made remarkable advancements in understanding antibiotic resistance and bacterial pathogenesis, earning prestigious awards and international recognition. His technical skills in genomics, pathology, and bioinformatics further enhance his contributions to disease control and prevention. As an active member of professional organizations and a reviewer for high-impact journals, Dr. Hussain continues to influence the field of veterinary medicine. His commitment to scientific excellence and student mentorship underscores his vision for a healthier future in veterinary and public health. His work remains instrumental in shaping the next generation of veterinary professionals and improving animal health through innovative research and education.

Publications Top Notes

  1. “Optimization and production of highly stable amylase isolated from Citrobacter portucalensis using low-cost agro-industrial wastes as substrates: Prospective therapeutics”

    • Authors: Ume E. Salma Liaqat, Shumaila Naz, Hafiz Iftikhar Hussain
    • Year: 2024
    • Journal: Kuwait Journal of Science

  2. “Phytochemical Screening, Anti-Inflammatory, and Antidiabetic Activities of Different Extracts from Caralluma edulis Plant”

    • Authors: Maria Khan, Zahid Manzoor, Muhammad Q. Rafiq, Katarzyna Kotwica-Mojzych, Mariusz Mojzych
    • Year: 2022
    • Journal: Molecules
    • Citations: 9

 

Mycal Dutta | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Dr. Mycal Dutta | Pharmaceutical Science | Best Researcher Award

Associate Professor at University of Science and Technology (USTC), Bangladesh

Dr. Mycal Dutta is an accomplished Associate Professor in the Department of Pharmacy at the University of Science and Technology Chittagong (USTC), Bangladesh. With nearly fourteen years of experience in academia, research, and professional practice, he has made significant contributions to pharmaceutical sciences. Dr. Dutta earned his Ph.D. in Pharmacy from Jahangirnagar University, Dhaka, in December 2022. His expertise spans pharmaceutical technology, microbiology, and clinical pharmacy. He has published 36 research papers in national and international journals, focusing on bioactive phytochemicals, drug formulation, and pharmacological investigations. As a registered “A” Grade Pharmacist, he actively contributes to professional training and advisory committees. His research interests include the isolation of medicinal plant compounds, computational drug design, and molecular docking studies. Dr. Dutta has received several research grants, including government-funded projects on ethnomedicinal plants. Apart from his academic roles, he has been involved in organizing scientific conferences and student welfare activities. His commitment to teaching, research, and pharmaceutical advancements has made him a distinguished figure in the field.

Professional Profile

Education

Dr. Mycal Dutta has a strong academic background in pharmacy. He obtained his Ph.D. in Pharmacy from Jahangirnagar University, Dhaka, in December 2022. Prior to this, he completed his Master of Pharmacy (Thesis) degree from Southern University, Bangladesh, in 2011, achieving a CGPA of 3.6 on a 4.0 scale. He earned his Bachelor of Pharmacy (Hons.) degree from the University of Science and Technology Chittagong (USTC) in 2009, graduating with First Class honors. His foundational education includes a Higher Secondary Certificate (HSC) from Govt. Hazi Muhammad Mohsin College, Chittagong, with a GPA of 4.70 out of 5.00 in 2004, and a Secondary School Certificate (SSC) from Collegiate School, Chittagong, with a GPA of 4.38 out of 5.00 in 2002. His educational journey reflects his dedication to academic excellence and pharmaceutical sciences.

Professional Experience

Dr. Mycal Dutta has extensive teaching and research experience in the field of pharmacy. He has been serving as an Associate Professor at the University of Science and Technology Chittagong (USTC) since July 2023. Previously, he worked as an Assistant Professor at BGC Trust University Bangladesh for nearly eight years (2015–2023) and as a Lecturer at the same institution for almost five years (2011–2015). In addition to his teaching roles, he has contributed significantly to academic administration, including serving as an advisor in the Student Welfare Advisory Committee at USTC and as Chief Advisor of the Career Development and Placement Club at BGC Trust University. His professional contributions extend to chairing scientific and publication committees for national conferences and participating in examination committees. His vast experience demonstrates his dedication to pharmacy education and academic leadership.

Research Interests

Dr. Mycal Dutta’s research interests focus on pharmacological and phytochemical investigations of medicinal plants. His work involves compound isolation using techniques such as Nuclear Magnetic Resonance (NMR) and Gas Chromatography-Mass Spectrometry (GC-MS). He is particularly interested in computational drug discovery, molecular docking, Quantitative Structure-Activity Relationship (QSAR) modeling, and ADME/T property analysis of natural compounds. His research aims to bridge wet lab and dry lab approaches to develop therapeutic solutions from natural products. He also explores antimicrobial studies, aseptic techniques, bacterial staining, and in vitro and in vivo pharmacological investigations. His research contributions significantly advance the understanding of bioactive phytochemicals and their therapeutic potential.

Research Skills

Dr. Mycal Dutta possesses a diverse range of research skills, including microbiological techniques such as aseptic handling, bacterial staining, and antimicrobial sensitivity testing. He is proficient in computational drug design, protein modeling, and molecular simulations. His technical expertise extends to animal research, including transgenic and knockout mouse models. He is skilled in using various molecular modeling and Computer-Aided Drug Design (CADD) software. Additionally, he has extensive experience with statistical analysis tools such as GraphPad Prism and SPSS. His proficiency in these areas enables him to conduct high-quality research and mentor students in advanced pharmaceutical investigations.

Awards and Honors

Dr. Mycal Dutta has received several prestigious research grants and recognitions. He was awarded the R&D Grant for Science and Technology (2022–2023) from the Ministry of Science and Technology, Bangladesh, for his research on bioactive phytochemicals. Additionally, he secured a research grant from BGC Trust University Bangladesh in 2017 to support his Ph.D. research. His contributions to pharmaceutical research have been acknowledged through numerous publications in high-impact journals. He has also played a key role in organizing national conferences and scientific symposiums. His commitment to research and academia has earned him a strong reputation in the field of pharmaceutical sciences.

Conclusion

Dr. Mycal Dutta is a dedicated researcher, educator, and pharmaceutical scientist committed to advancing pharmaceutical education and research. With nearly fourteen years of experience, he has made remarkable contributions to pharmacology, phytochemistry, and drug discovery. His extensive research on medicinal plants and computational drug design has positioned him as a leading expert in the field. His passion for teaching, mentoring students, and conducting groundbreaking research continues to impact the pharmaceutical sciences significantly. Through his academic leadership, professional affiliations, and research initiatives, he remains at the forefront of pharmaceutical innovation and education.

Publications Top Notes

  1. Yusuf, A., Shaikat, M. A., Bhuiya, M. A. M., Dutta, M., Nath, A. K., & Dash, P. R. (2023). Utilizing the Medicinal Properties of Delonix regia for Diseases and Beyond: A Review of its Phytochemistry and Pharmacology. Tropical Journal of Natural Product Research, 7(12), 5355–5365. DOI: 10.26538/tjnpr/v7i12.2

  2. Malini, S., Raj, K., Madhumathy, S., El-Hady, K. M., Islam, S., & Dutta, M. (2022). Bioinspired Advances in Nanomaterials for Sustainable Agriculture. Journal of Nanomaterials, 2022, Article ID 8926133. DOI: 10.1155/2022/8926133

  3. Vaidya, S., Jeengar, M., Wadaan, M. A., Mahboob, S., Kumar, P., Reece, L. M., Bathula, S. R., & Dutta, M. (2022). Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID 9231641. DOI: 10.1155/2022/9231641

  4. Jadhav, V., Bhagare, A., Wahab, S., Lokhande, D., Vaidya, C., Dhayagude, A., Khalid, M., Aher, J., Mezni, A., & Dutta, M. (2022). Green Synthesized Calcium Oxide Nanoparticles (CaO NPs) Using Leaves Aqueous Extract of Moringa oleifera and Evaluation of Their Antibacterial Activities. Journal of Nanomaterials, 2022, Article ID 9047507. DOI: 10.1155/2022/9047507

  5. Jadhav, V., Bhagare, A., Ali, I. H., Dhayagude, A., Lokhande, D., Aher, J., Jameel, M., & Dutta, M. (2022). Role of Moringa oleifera on Green Synthesis of Metal/Metal Oxide Nanomaterials. Journal of Nanomaterials, 2022, Article ID 2147393. DOI: 10.1155/2022/2147393

  6. Alharthy, S. A., Shams Tabrez, S., Ahmed A. Mirza, A. A., Torki A. Zughaibi, Firoz, C. K., & Dutta, M. (2022). Sugiol Suppresses the Proliferation of Human U87 Glioma Cells via Induction of Apoptosis and Cell Cycle Arrest. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID 7658899. DOI: 10.1155/2022/7658899

  7. Dutta, M., Akter, T., Nezam, M., Paul, A., & Rana, M. S. (2022). In silico Molecular Docking and ADME/T Analysis of Selected Bioactive Compounds from Leucas zeylanica against Breast Cancer. BGC Trust University Journal, 6, 51–66.

  8. Dutta, M., Tareq, A. M., Rakib, A., Mahmud, S., Sami, S. A., Mallick, J., Islam, M. N., Majumder, M., Uddin, M. Z., Alsubaie, A., & Almalki, A. S. (2021). Phytochemicals from Leucas zeylanica Targeting Main Protease of SARS-CoV-2: Chemical Profiles, Molecular Docking, and Molecular Dynamics Simulations. Biology, 10(8), 789. DOI: 10.3390/biology10080789

  9. Dutta, M., Nezam, M., Chowdhury, S., Rakib, A., Paul, A., Sami, S. A., Uddin, M. Z., Rana, M. S., Hossain, S., Effendi, Y., Idroes, R., Tallei, T. E., Alqahtani, A. M., & Emran, T. B. (2021). Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach. Frontiers in Molecular Biosciences, 8, 625391. DOI: 10.3389/fmolb.2021.625391

  10. Rakib, A., Paul, A., Ahmed, S., Chy, M. N. U., Baral, S. K., Majumder, M., Tareq, A. T., Amin, M. N., Shahriar, A., Uddin, M. Z., Dutta, M., Tallei, T. E., Emran, T. B., & Simal-Gandara, J. (2020). Biochemical and Computational Approach of Phytocompounds from Tinospora crispa in the Management of COVID-19: Molecules; 25(17): E3936. DOI: 10.3390/molecules25173936